ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
1,061.00
+3.00 (0.28%)
Last updated: Aug 6, 2025
Accolade Revenue
ChoA Pharmaceutical Co., LTD. had revenue of 14.37B KRW in the quarter ending March 31, 2025, a decrease of -5.04%. This brings the company's revenue in the last twelve months to 61.93B, down -0.53% year-over-year. In the year 2024, ChoA Pharmaceutical Co., LTD. had annual revenue of 62.69B, down -0.44%.
Revenue (ttm)
61.93B
Revenue Growth
-0.53%
P/S Ratio
0.53
Revenue / Employee
247.72M
Employees
250
Market Cap
32.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
Dec 31, 2020 | 65.36B | -2.18B | -3.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
KB Financial Group | 15.69T |